JP2012530084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012530084A5 JP2012530084A5 JP2012515322A JP2012515322A JP2012530084A5 JP 2012530084 A5 JP2012530084 A5 JP 2012530084A5 JP 2012515322 A JP2012515322 A JP 2012515322A JP 2012515322 A JP2012515322 A JP 2012515322A JP 2012530084 A5 JP2012530084 A5 JP 2012530084A5
- Authority
- JP
- Japan
- Prior art keywords
- diazatricyclo
- undecane
- pyridin
- heteroaryl
- monocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000000217 alkyl group Chemical group 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 27
- 125000001188 haloalkyl group Chemical group 0.000 claims 21
- 125000001072 heteroaryl group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- 125000004432 carbon atom Chemical group C* 0.000 claims 9
- 208000035475 disorder Diseases 0.000 claims 9
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 208000002193 Pain Diseases 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000002950 monocyclic group Chemical group 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- -1 1,3-thiazolyl Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 208000010877 cognitive disease Diseases 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 201000000980 schizophrenia Diseases 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 239000004215 Carbon black (E152) Substances 0.000 claims 3
- 208000028698 Cognitive impairment Diseases 0.000 claims 3
- 206010012289 Dementia Diseases 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 3
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 229930195733 hydrocarbon Natural products 0.000 claims 3
- 150000002430 hydrocarbons Chemical class 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000001544 thienyl group Chemical group 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 2
- 208000004454 Hyperalgesia Diseases 0.000 claims 2
- 208000005298 acute pain Diseases 0.000 claims 2
- 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 claims 2
- 239000003693 atypical antipsychotic agent Substances 0.000 claims 2
- 229940127236 atypical antipsychotics Drugs 0.000 claims 2
- LCIYFINKFGDAHD-UHFFFAOYSA-N azepane;3-nitrobenzoic acid Chemical compound C1CCCNCC1.OC(=O)C1=CC=CC([N+]([O-])=O)=C1 LCIYFINKFGDAHD-UHFFFAOYSA-N 0.000 claims 2
- 125000002619 bicyclic group Chemical group 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 230000007812 deficiency Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 206010027175 memory impairment Diseases 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 201000001119 neuropathy Diseases 0.000 claims 2
- 230000007823 neuropathy Effects 0.000 claims 2
- 108010052671 nicotinic receptor alpha4beta2 Proteins 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- UFEPSYPWWUXPPQ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)methanone Chemical compound C1=C(Cl)C(F)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 UFEPSYPWWUXPPQ-UHFFFAOYSA-N 0.000 claims 1
- APMHSXJCMXBHJY-UHFFFAOYSA-N (3-chlorophenyl)-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)methanone Chemical compound ClC1=CC=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 APMHSXJCMXBHJY-UHFFFAOYSA-N 0.000 claims 1
- GVOXZLAEIZBSPH-UHFFFAOYSA-N (5-chloro-2-fluorophenyl)-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)methanone Chemical compound FC1=CC=C(Cl)C=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 GVOXZLAEIZBSPH-UHFFFAOYSA-N 0.000 claims 1
- ZAJVRLDMHXFICV-UHFFFAOYSA-N (5-chloro-2-methoxyphenyl)-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)methanone Chemical compound COC1=CC=C(Cl)C=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 ZAJVRLDMHXFICV-UHFFFAOYSA-N 0.000 claims 1
- XRRUCMXUIAATKQ-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(1,2,3,4-tetrahydronaphthalen-2-yl)methanone Chemical compound C1CC2=CC=CC=C2CC1C(=O)N1CC(C2)CN3CC1CC2C3 XRRUCMXUIAATKQ-UHFFFAOYSA-N 0.000 claims 1
- YNRCDWSRGVZPCH-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(1H-indazol-3-yl)methanone Chemical compound N=1NC2=CC=CC=C2C=1C(=O)N1CC(C2)CN3CC1CC2C3 YNRCDWSRGVZPCH-UHFFFAOYSA-N 0.000 claims 1
- PCPNXIMJIARXAV-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(1H-indol-5-yl)methanone Chemical compound C=1C=C2NC=CC2=CC=1C(=O)N1CC(C2)CN3CC1CC2C3 PCPNXIMJIARXAV-UHFFFAOYSA-N 0.000 claims 1
- KLCDVRMTMVKZCC-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(1H-pyrrol-2-yl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CN1 KLCDVRMTMVKZCC-UHFFFAOYSA-N 0.000 claims 1
- ONZFIUXTTRXGFK-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(furan-2-yl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CO1 ONZFIUXTTRXGFK-UHFFFAOYSA-N 0.000 claims 1
- CEKNKWVIDWJMBP-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(phenyl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CC=C1 CEKNKWVIDWJMBP-UHFFFAOYSA-N 0.000 claims 1
- IFFHDIHUAJIEKP-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(pyridin-2-yl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CC=N1 IFFHDIHUAJIEKP-UHFFFAOYSA-N 0.000 claims 1
- FUJXILCZCPMXSN-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(pyridin-3-yl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CN=C1 FUJXILCZCPMXSN-UHFFFAOYSA-N 0.000 claims 1
- DXALTJUIQNYPOE-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(quinolin-2-yl)methanone Chemical compound C=1C=C2C=CC=CC2=NC=1C(=O)N1CC(C2)CN3CC1CC2C3 DXALTJUIQNYPOE-UHFFFAOYSA-N 0.000 claims 1
- QZFQDVLIAQNSLM-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(thieno[2,3-c]pyridin-5-yl)methanone Chemical compound C=1C=2C=CSC=2C=NC=1C(=O)N1CC(C2)CN3CC1CC2C3 QZFQDVLIAQNSLM-UHFFFAOYSA-N 0.000 claims 1
- PZIWBLGELKZIOQ-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(thieno[3,2-b]pyridin-5-yl)methanone Chemical compound C=1C=C2SC=CC2=NC=1C(=O)N1CC(C2)CN3CC1CC2C3 PZIWBLGELKZIOQ-UHFFFAOYSA-N 0.000 claims 1
- GTWISGOTEDNEDS-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl(thiophen-2-yl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CS1 GTWISGOTEDNEDS-UHFFFAOYSA-N 0.000 claims 1
- GCZBWMHAHNWILC-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(1-methylpyrrol-2-yl)methanone Chemical compound CN1C=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 GCZBWMHAHNWILC-UHFFFAOYSA-N 0.000 claims 1
- KUSBBTYCOSBTQH-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2,3-difluorophenyl)methanone Chemical compound FC1=CC=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1F KUSBBTYCOSBTQH-UHFFFAOYSA-N 0.000 claims 1
- CFAOLDAIGUJGHQ-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2,3-dimethylphenyl)methanone Chemical compound CC1=CC=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1C CFAOLDAIGUJGHQ-UHFFFAOYSA-N 0.000 claims 1
- SWQXKWMAAILBPF-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2,4-difluorophenyl)methanone Chemical compound FC1=CC(F)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 SWQXKWMAAILBPF-UHFFFAOYSA-N 0.000 claims 1
- CQXUWLSOJJLWGZ-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2,5-dimethylfuran-3-yl)methanone Chemical compound O1C(C)=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1C CQXUWLSOJJLWGZ-UHFFFAOYSA-N 0.000 claims 1
- IZUQKAOYIKFKRV-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2,5-dimethylphenyl)methanone Chemical compound CC1=CC=C(C)C(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 IZUQKAOYIKFKRV-UHFFFAOYSA-N 0.000 claims 1
- RWFPJTRYQPDMRK-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2-fluorophenyl)methanone Chemical compound FC1=CC=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 RWFPJTRYQPDMRK-UHFFFAOYSA-N 0.000 claims 1
- UFDSVRIDRGHVGO-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2-hydroxyphenyl)methanone Chemical compound OC1=CC=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 UFDSVRIDRGHVGO-UHFFFAOYSA-N 0.000 claims 1
- KRKKJEJPMRKTQF-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2-methoxypyridin-3-yl)methanone Chemical compound COC1=NC=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 KRKKJEJPMRKTQF-UHFFFAOYSA-N 0.000 claims 1
- BPWSKNYQZWQJDU-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 BPWSKNYQZWQJDU-UHFFFAOYSA-N 0.000 claims 1
- YHWZDXDPTGGNCD-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(2-phenylpyrazol-3-yl)methanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=NN1C1=CC=CC=C1 YHWZDXDPTGGNCD-UHFFFAOYSA-N 0.000 claims 1
- YFJGHGINAYHYDD-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(3,4-difluorophenyl)methanone Chemical compound C1=C(F)C(F)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 YFJGHGINAYHYDD-UHFFFAOYSA-N 0.000 claims 1
- YPKSWMNMPQVBAI-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(3-methoxyphenyl)methanone Chemical compound COC1=CC=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 YPKSWMNMPQVBAI-UHFFFAOYSA-N 0.000 claims 1
- JDIMGWXPYSSYJB-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(3-methylfuran-2-yl)methanone Chemical compound C1=COC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1C JDIMGWXPYSSYJB-UHFFFAOYSA-N 0.000 claims 1
- UCTXCLORTHSTEI-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(3-methylphenyl)methanone Chemical compound CC1=CC=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 UCTXCLORTHSTEI-UHFFFAOYSA-N 0.000 claims 1
- KHPXCMPGVLSQGL-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(4-ethoxyphenyl)methanone Chemical compound C1=CC(OCC)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 KHPXCMPGVLSQGL-UHFFFAOYSA-N 0.000 claims 1
- ZEZDFSCWDVNANX-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(4-ethylphenyl)methanone Chemical compound C1=CC(CC)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 ZEZDFSCWDVNANX-UHFFFAOYSA-N 0.000 claims 1
- DOHMMCTWKDFNOR-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(4-fluoro-3-methylphenyl)methanone Chemical compound C1=C(F)C(C)=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 DOHMMCTWKDFNOR-UHFFFAOYSA-N 0.000 claims 1
- SFGXHAYOZZIXGD-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(4-methylthiophen-2-yl)methanone Chemical compound CC1=CSC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 SFGXHAYOZZIXGD-UHFFFAOYSA-N 0.000 claims 1
- QSYRECSJNCDMBN-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-(5-methylthiophen-2-yl)methanone Chemical compound S1C(C)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 QSYRECSJNCDMBN-UHFFFAOYSA-N 0.000 claims 1
- HDNGCJMRFKVVBA-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl-[4-(dimethylamino)phenyl]methanone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 HDNGCJMRFKVVBA-UHFFFAOYSA-N 0.000 claims 1
- QSJXHKFTZFDXSD-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecan-5-one Chemical group O=C1NC(C2)CN3CC1CC2C3 QSJXHKFTZFDXSD-UHFFFAOYSA-N 0.000 claims 1
- JMJUWQIOHYBWPM-UHFFFAOYSA-N 1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1N(C2)CC3CC2CNC1C3 JMJUWQIOHYBWPM-UHFFFAOYSA-N 0.000 claims 1
- ADVUOUWNIKBLTH-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-(2,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(OC)C(CC(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 ADVUOUWNIKBLTH-UHFFFAOYSA-N 0.000 claims 1
- MOCKOLWUTUXVSD-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-(2-fluorophenyl)ethanone Chemical compound FC1=CC=CC=C1CC(=O)N1C(CN(C2)C3)CC2CC3C1 MOCKOLWUTUXVSD-UHFFFAOYSA-N 0.000 claims 1
- GUIMUEYGRLWUGA-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-(2-methylphenyl)ethanone Chemical compound CC1=CC=CC=C1CC(=O)N1C(CN(C2)C3)CC2CC3C1 GUIMUEYGRLWUGA-UHFFFAOYSA-N 0.000 claims 1
- NYICTSAADDDOBB-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(CC(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 NYICTSAADDDOBB-UHFFFAOYSA-N 0.000 claims 1
- KSUCWFSMUCLSQZ-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-(3-methylphenyl)ethanone Chemical compound CC1=CC=CC(CC(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 KSUCWFSMUCLSQZ-UHFFFAOYSA-N 0.000 claims 1
- VEDIHKHAUHTSBD-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-[2-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=CC=CC=C1CC(=O)N1C(CN(C2)C3)CC2CC3C1 VEDIHKHAUHTSBD-UHFFFAOYSA-N 0.000 claims 1
- XRSVWIJDRKTJFX-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-[4-(dimethylamino)phenyl]ethanone Chemical compound C1=CC(N(C)C)=CC=C1CC(=O)N1C(CN(C2)C3)CC2CC3C1 XRSVWIJDRKTJFX-UHFFFAOYSA-N 0.000 claims 1
- HBYVZFDLBOFHAK-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-phenoxyethanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)COC1=CC=CC=C1 HBYVZFDLBOFHAK-UHFFFAOYSA-N 0.000 claims 1
- GEDLNOAXRZAKME-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-thiophen-2-ylethanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)CC1=CC=CS1 GEDLNOAXRZAKME-UHFFFAOYSA-N 0.000 claims 1
- DIUWEZWCUHHKBX-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-2-thiophen-3-ylethanone Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)CC=1C=CSC=1 DIUWEZWCUHHKBX-UHFFFAOYSA-N 0.000 claims 1
- NUODDFYENHDLFJ-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-3-phenylbutan-1-one Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)CC(C)C1=CC=CC=C1 NUODDFYENHDLFJ-UHFFFAOYSA-N 0.000 claims 1
- KAWVLRZQIHCMIR-UHFFFAOYSA-N 1-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-3-phenylpropan-1-one Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)CCC1=CC=CC=C1 KAWVLRZQIHCMIR-UHFFFAOYSA-N 0.000 claims 1
- BSHJNFRDMXVCBN-UHFFFAOYSA-N 1-{2-[5-(1,4-diazatricyclo[4.3.1.13,8]undec-4-yl)pyridin-3-yl]phenyl}ethanone Chemical compound CC(=O)C1=CC=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 BSHJNFRDMXVCBN-UHFFFAOYSA-N 0.000 claims 1
- HTIKEGIKZQYHTO-UHFFFAOYSA-N 2-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-5-phenyl-1,3,4-oxadiazole Chemical compound C1C(C2)CC3CN2CC1CN3C(O1)=NN=C1C1=CC=CC=C1 HTIKEGIKZQYHTO-UHFFFAOYSA-N 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- TWPWFUABIMXXNA-UHFFFAOYSA-N 3-(1,4-diazatricyclo[4.3.1.13,8]undecane-4-carbonyl)benzonitrile Chemical compound C1C(CN(C2)C3)CC2CC3N1C(=O)C1=CC=CC(C#N)=C1 TWPWFUABIMXXNA-UHFFFAOYSA-N 0.000 claims 1
- RJBVGJISFOPTFT-UHFFFAOYSA-N 3-[5-(1,4-diazatricyclo[4.3.1.13,8]undec-4-yl)pyridin-3-yl]benzonitrile Chemical compound N#CC1=CC=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 RJBVGJISFOPTFT-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- FMZSEQGKTBYAQF-UHFFFAOYSA-N 4-(2'-methoxy-3,3'-bipyridin-5-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=NC=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 FMZSEQGKTBYAQF-UHFFFAOYSA-N 0.000 claims 1
- PQNNOZBBJMKALN-UHFFFAOYSA-N 4-(3,3'-bipyridin-5-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(C=1)=CN=CC=1C1=CC=CN=C1 PQNNOZBBJMKALN-UHFFFAOYSA-N 0.000 claims 1
- PIMZMCBEVCTHJG-UHFFFAOYSA-N 4-(3,4'-bipyridin-5-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(C=1)=CN=CC=1C1=CC=NC=C1 PIMZMCBEVCTHJG-UHFFFAOYSA-N 0.000 claims 1
- ATXIRBFCMDQDEI-UHFFFAOYSA-N 4-(5-phenylpyridin-3-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(C=1)=CN=CC=1C1=CC=CC=C1 ATXIRBFCMDQDEI-UHFFFAOYSA-N 0.000 claims 1
- NHAYNWYYSQZXJY-UHFFFAOYSA-N 4-(5-pyrimidin-5-ylpyridin-3-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(C=1)=CN=CC=1C1=CN=CN=C1 NHAYNWYYSQZXJY-UHFFFAOYSA-N 0.000 claims 1
- KACKMVSHTHREKN-UHFFFAOYSA-N 4-(5-thien-3-ylpyridin-3-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(C=1)=CN=CC=1C=1C=CSC=1 KACKMVSHTHREKN-UHFFFAOYSA-N 0.000 claims 1
- YSYMKKUCVPYTFS-UHFFFAOYSA-N 4-(6'-methoxy-3,3'-bipyridin-5-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=NC(OC)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 YSYMKKUCVPYTFS-UHFFFAOYSA-N 0.000 claims 1
- RVITZLSAWXNUEF-UHFFFAOYSA-N 4-(6-phenylpyridazin-3-yl)-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(N=N1)=CC=C1C1=CC=CC=C1 RVITZLSAWXNUEF-UHFFFAOYSA-N 0.000 claims 1
- KIOSKKDQGGKKST-UHFFFAOYSA-N 4-[5-(1,3-benzodioxol-5-yl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=C2OCOC2=CC=C1C(C=1)=CN=CC=1N1CC(C2)CN3CC1CC2C3 KIOSKKDQGGKKST-UHFFFAOYSA-N 0.000 claims 1
- ZJNLAVSXJIKECX-UHFFFAOYSA-N 4-[5-(1,4-diazatricyclo[4.3.1.13,8]undec-4-yl)pyridin-3-yl]benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 ZJNLAVSXJIKECX-UHFFFAOYSA-N 0.000 claims 1
- WPQDLLMSCZWDEJ-UHFFFAOYSA-N 4-[5-(1h-indol-4-yl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C2CN(C3)CC1CC3CN2C1=CN=CC(C=2C=3C=CNC=3C=CC=2)=C1 WPQDLLMSCZWDEJ-UHFFFAOYSA-N 0.000 claims 1
- CTTMUMGDXREYPF-UHFFFAOYSA-N 4-[5-(1h-indol-5-yl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C2CN(C3)CC1CC3CN2C1=CN=CC(C=2C=C3C=CNC3=CC=2)=C1 CTTMUMGDXREYPF-UHFFFAOYSA-N 0.000 claims 1
- ZMZAWFHVBIEZPJ-UHFFFAOYSA-N 4-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C=1C=C2OCCOC2=CC=1C(C=1)=CN=CC=1N1CC(C2)CN3CC1CC2C3 ZMZAWFHVBIEZPJ-UHFFFAOYSA-N 0.000 claims 1
- XIONOBLQJKVDSK-UHFFFAOYSA-N 4-[5-(2,4-dimethoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC(OC)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 XIONOBLQJKVDSK-UHFFFAOYSA-N 0.000 claims 1
- ZRPZGHPWJBLDOX-UHFFFAOYSA-N 4-[5-(2,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC=C(OC)C(C=2SC(=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 ZRPZGHPWJBLDOX-UHFFFAOYSA-N 0.000 claims 1
- FGTXRZGKRZEKIX-UHFFFAOYSA-N 4-[5-(2,5-dimethoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC=C(OC)C(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 FGTXRZGKRZEKIX-UHFFFAOYSA-N 0.000 claims 1
- NWRUTVZSLNWRFV-UHFFFAOYSA-N 4-[5-(2,6-dimethoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC=CC(OC)=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 NWRUTVZSLNWRFV-UHFFFAOYSA-N 0.000 claims 1
- KBGSTNFZVBVGQO-UHFFFAOYSA-N 4-[5-(2-ethoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound CCOC1=CC=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 KBGSTNFZVBVGQO-UHFFFAOYSA-N 0.000 claims 1
- ZCNPITMKMRMZMF-UHFFFAOYSA-N 4-[5-(2-fluorophenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound FC1=CC=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 ZCNPITMKMRMZMF-UHFFFAOYSA-N 0.000 claims 1
- RBXLYILUSREKEI-UHFFFAOYSA-N 4-[5-(2-furyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1C(C2)CC3CN2CC1CN3C(C=1)=CN=CC=1C1=CC=CO1 RBXLYILUSREKEI-UHFFFAOYSA-N 0.000 claims 1
- RLNLSHKJIAQDOD-UHFFFAOYSA-N 4-[5-(2-methoxy-5-methylphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC=C(C)C=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 RLNLSHKJIAQDOD-UHFFFAOYSA-N 0.000 claims 1
- KHJMWUYNLILICL-UHFFFAOYSA-N 4-[5-(2-methoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 KHJMWUYNLILICL-UHFFFAOYSA-N 0.000 claims 1
- MYRADNWLNRLISR-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=C(OC)C(OC)=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 MYRADNWLNRLISR-UHFFFAOYSA-N 0.000 claims 1
- NXZCRZSLFPLPQB-UHFFFAOYSA-N 4-[5-(3,4-difluorophenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=C(F)C(F)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 NXZCRZSLFPLPQB-UHFFFAOYSA-N 0.000 claims 1
- WATSKJHQPGQTBY-UHFFFAOYSA-N 4-[5-(3,4-dimethoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=C(OC)C(OC)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 WATSKJHQPGQTBY-UHFFFAOYSA-N 0.000 claims 1
- YWVOGOKVELDKRZ-UHFFFAOYSA-N 4-[5-(3,5-dimethylisoxazol-4-yl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound CC1=NOC(C)=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 YWVOGOKVELDKRZ-UHFFFAOYSA-N 0.000 claims 1
- RDJCJGGWKBHSFT-UHFFFAOYSA-N 4-[5-(3-fluoro-4-methoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=C(F)C(OC)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 RDJCJGGWKBHSFT-UHFFFAOYSA-N 0.000 claims 1
- VXTNQLZUBBXVIT-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)-1,3-thiazol-2-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound FC1=CC=CC(C=2SC(=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 VXTNQLZUBBXVIT-UHFFFAOYSA-N 0.000 claims 1
- CLPJRBSNJPBIGL-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound FC1=CC=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 CLPJRBSNJPBIGL-UHFFFAOYSA-N 0.000 claims 1
- HBZCNQPFTVULRE-UHFFFAOYSA-N 4-[5-(3-methoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound COC1=CC=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 HBZCNQPFTVULRE-UHFFFAOYSA-N 0.000 claims 1
- KWRIOEIZWGBFLY-UHFFFAOYSA-N 4-[5-(3-methylphenyl)-1,3-thiazol-2-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound CC1=CC=CC(C=2SC(=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 KWRIOEIZWGBFLY-UHFFFAOYSA-N 0.000 claims 1
- JCLXLBNDMPMYQA-UHFFFAOYSA-N 4-[5-(3-methylphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound CC1=CC=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 JCLXLBNDMPMYQA-UHFFFAOYSA-N 0.000 claims 1
- XGYFUALJXMFBSC-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(F)=CC=C1C1=CN=C(N2C3CC4CC(CN(C4)C3)C2)S1 XGYFUALJXMFBSC-UHFFFAOYSA-N 0.000 claims 1
- ZKCFCHIQOYRQHA-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(F)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 ZKCFCHIQOYRQHA-UHFFFAOYSA-N 0.000 claims 1
- LLUZHZHYJACABD-UHFFFAOYSA-N 4-[5-(4-methoxy-3-methylphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=C(C)C(OC)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 LLUZHZHYJACABD-UHFFFAOYSA-N 0.000 claims 1
- PUKDMCGPIQUYKV-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(OC)=CC=C1C1=CN=C(N2C3CC4CC(CN(C4)C3)C2)S1 PUKDMCGPIQUYKV-UHFFFAOYSA-N 0.000 claims 1
- NAIPNGXJVCWTIE-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 NAIPNGXJVCWTIE-UHFFFAOYSA-N 0.000 claims 1
- NUIZJDPZDQDCGP-UHFFFAOYSA-N 4-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(C)=CC=C1C1=CN=C(N2C3CC4CC(CN(C4)C3)C2)S1 NUIZJDPZDQDCGP-UHFFFAOYSA-N 0.000 claims 1
- AWSZBXBJCKGVMR-UHFFFAOYSA-N 4-[5-(4-methylphenyl)pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(C)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 AWSZBXBJCKGVMR-UHFFFAOYSA-N 0.000 claims 1
- ZBKFRTYDZSVFCU-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound FC(F)(F)C1=CC=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 ZBKFRTYDZSVFCU-UHFFFAOYSA-N 0.000 claims 1
- CYNHGMMOXWHBJD-UHFFFAOYSA-N 4-{5-[4-(trifluoromethyl)phenyl]pyridin-3-yl}-1,4-diazatricyclo[4.3.1.13,8]undecane Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 CYNHGMMOXWHBJD-UHFFFAOYSA-N 0.000 claims 1
- KAGXFUWTXHPIIF-UHFFFAOYSA-N 6-chloro-2-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-1,3-benzothiazole Chemical compound S1C2=CC(Cl)=CC=C2N=C1N1CC(C2)CN3CC1CC2C3 KAGXFUWTXHPIIF-UHFFFAOYSA-N 0.000 claims 1
- YWXCQJAUQKTABK-UHFFFAOYSA-N 6-chloro-2-(1,4-diazatricyclo[4.3.1.13,8]undecan-4-yl)-1,3-benzoxazole Chemical compound O1C2=CC(Cl)=CC=C2N=C1N1CC(C2)CN3CC1CC2C3 YWXCQJAUQKTABK-UHFFFAOYSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- MGLMYWBWIOOWFD-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 MGLMYWBWIOOWFD-UHFFFAOYSA-N 0.000 claims 1
- KSQMYSXLVHHAPH-UHFFFAOYSA-N C1C2CN(C3)CC1CC3CN2C1=CC=C(C=2C=C3C=CSC3=CC=2)N=N1 Chemical compound C1C2CN(C3)CC1CC3CN2C1=CC=C(C=2C=C3C=CSC3=CC=2)N=N1 KSQMYSXLVHHAPH-UHFFFAOYSA-N 0.000 claims 1
- NAIXNNZMFDZEQH-UHFFFAOYSA-N C=1C=CC2=CC=CC=C2C=1CC(=O)N1CC(C2)CN3CC1CC2C3 Chemical compound C=1C=CC2=CC=CC=C2C=1CC(=O)N1CC(C2)CN3CC1CC2C3 NAIXNNZMFDZEQH-UHFFFAOYSA-N 0.000 claims 1
- WPUCERXSCHMLSF-UHFFFAOYSA-N CC1=CC(C)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 Chemical compound CC1=CC(C)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 WPUCERXSCHMLSF-UHFFFAOYSA-N 0.000 claims 1
- RONOYDSQKYPSFK-UHFFFAOYSA-N COC1=CC(OC)=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 Chemical compound COC1=CC(OC)=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 RONOYDSQKYPSFK-UHFFFAOYSA-N 0.000 claims 1
- VCURZMGVHLLHAJ-UHFFFAOYSA-N COC1=CC=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 Chemical compound COC1=CC=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 VCURZMGVHLLHAJ-UHFFFAOYSA-N 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- 208000005171 Dysmenorrhea Diseases 0.000 claims 1
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 206010015958 Eye pain Diseases 0.000 claims 1
- KASIVDHXHULHQW-UHFFFAOYSA-N FC1=CC(F)=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 Chemical compound FC1=CC(F)=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 KASIVDHXHULHQW-UHFFFAOYSA-N 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 201000011240 Frontotemporal dementia Diseases 0.000 claims 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 206010026749 Mania Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- QMKNDDIPPJRAOJ-UHFFFAOYSA-N N-[3-(1,4-diazatricyclo[4.3.1.13,8]undecane-4-carbonyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C(=O)N2C3CC4CC(CN(C4)C3)C2)=C1 QMKNDDIPPJRAOJ-UHFFFAOYSA-N 0.000 claims 1
- BYNUSNCVOAXSKW-UHFFFAOYSA-N N-[4-(1,4-diazatricyclo[4.3.1.13,8]undecane-4-carbonyl)phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C(=O)N1C(CN(C2)C3)CC2CC3C1 BYNUSNCVOAXSKW-UHFFFAOYSA-N 0.000 claims 1
- 208000028389 Nerve injury Diseases 0.000 claims 1
- 206010029240 Neuritis Diseases 0.000 claims 1
- 208000029726 Neurodevelopmental disease Diseases 0.000 claims 1
- 208000001294 Nociceptive Pain Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000000450 Pelvic Pain Diseases 0.000 claims 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 208000008765 Sciatica Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000016620 Tourette disease Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 206010053552 allodynia Diseases 0.000 claims 1
- 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 210000004558 lewy body Anatomy 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 208000027061 mild cognitive impairment Diseases 0.000 claims 1
- ZAWONKVNIZWHBH-UHFFFAOYSA-N n-{3-[5-(1,4-diazatricyclo[4.3.1.13,8]undec-4-yl)pyridin-3-yl]phenyl}acetamide Chemical compound CC(=O)NC1=CC=CC(C=2C=C(C=NC=2)N2C3CC4CC(CN(C4)C3)C2)=C1 ZAWONKVNIZWHBH-UHFFFAOYSA-N 0.000 claims 1
- HVOXWRSNNUEIDP-UHFFFAOYSA-N n-{4-[5-(1,4-diazatricyclo[4.3.1.13,8]undec-4-yl)pyridin-3-yl]phenyl}-n,n-dimethylamine Chemical compound C1=CC(N(C)C)=CC=C1C1=CN=CC(N2C3CC4CC(CN(C4)C3)C2)=C1 HVOXWRSNNUEIDP-UHFFFAOYSA-N 0.000 claims 1
- 230000008764 nerve damage Effects 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 1
- 230000000698 schizophrenic effect Effects 0.000 claims 1
- 230000005586 smoking cessation Effects 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
- 0 *N1C(CC(C2)C3)C*3CC2*1 Chemical compound *N1C(CC(C2)C3)C*3CC2*1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21847909P | 2009-06-19 | 2009-06-19 | |
| US61/218,479 | 2009-06-19 | ||
| PCT/CN2010/000889 WO2010145208A1 (en) | 2009-06-19 | 2010-06-18 | Diazahomoadamantane derivatives and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012530084A JP2012530084A (ja) | 2012-11-29 |
| JP2012530084A5 true JP2012530084A5 (enExample) | 2013-08-08 |
Family
ID=43354879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012515322A Ceased JP2012530084A (ja) | 2009-06-19 | 2010-06-18 | ジアザホモアダマンタン誘導体およびこの使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8846661B2 (enExample) |
| EP (1) | EP2443122B1 (enExample) |
| JP (1) | JP2012530084A (enExample) |
| KR (1) | KR20120044978A (enExample) |
| CN (1) | CN102459268A (enExample) |
| AU (1) | AU2010262643B2 (enExample) |
| BR (1) | BRPI1015043A2 (enExample) |
| CA (1) | CA2765466A1 (enExample) |
| IL (2) | IL216883A (enExample) |
| MX (1) | MX2011014019A (enExample) |
| NZ (1) | NZ597511A (enExample) |
| PE (1) | PE20121066A1 (enExample) |
| RU (2) | RU2549551C2 (enExample) |
| SG (1) | SG176921A1 (enExample) |
| WO (1) | WO2010145208A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2809028C (en) * | 2010-08-20 | 2019-04-09 | Research Triangle Institute | Nicotinic receptor compounds |
| CN103087001A (zh) * | 2011-11-03 | 2013-05-08 | 南京大学 | 香草酸的1，3，4-噁二唑衍生物及其制法和用途 |
| WO2014165090A1 (en) * | 2013-03-13 | 2014-10-09 | The Broad Institute, Inc. | Compounds for the treatment of tuberculosis |
| RU2552649C1 (ru) * | 2013-12-13 | 2015-06-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им. М.В. Ломоносова) | Душистые 5-бензил-1,3-диазаадамантан-6-оны |
| WO2015103005A1 (en) * | 2014-01-03 | 2015-07-09 | Research Institute At Nationwide Children's Hospital | Amphiphilic amine compounds and their use as therapeutic agents and nanocarriers |
| WO2016100184A1 (en) | 2014-12-16 | 2016-06-23 | Forum Pharmaceuticals, Inc. | Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors |
| JP2018516973A (ja) | 2015-06-10 | 2018-06-28 | フォーラム・ファーマシューティカルズ・インコーポレイテッドＦｏｒｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | α７−ニコチン性アセチルコリン受容体のアゴニストとしてのアミノベンゾイソオキサゾール化合物 |
| EP3334740A4 (en) | 2015-08-12 | 2019-02-06 | Axovant Sciences GmbH | GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF ALPHA 7-NICOTINIC ACETYLCHOLINE RECEPTORS |
| CN108697709A (zh) * | 2015-12-10 | 2018-10-23 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
| AU2018282154B2 (en) | 2017-06-05 | 2022-04-07 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| WO2019005993A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
| CN111182898B (zh) | 2017-06-28 | 2024-04-16 | Ptc医疗公司 | 用于治疗亨廷顿氏病的方法 |
| AU2019219678A1 (en) * | 2018-02-08 | 2020-08-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Heteroaryl compounds, pharmaceutical compositions thereof, and their therapeutic use |
| BR112020019373A2 (pt) | 2018-03-27 | 2020-12-29 | Ptc Therapeutics, Inc. | Compostos para o tratamento da doença de hutington |
| WO2020005877A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| EP3814360B8 (en) | 2018-06-27 | 2024-11-06 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| IL279688B2 (en) | 2018-06-27 | 2025-01-01 | Ptc Therapeutics Inc | Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4557865A (en) * | 1984-05-07 | 1985-12-10 | Pennwalt Corporation | Substituted 4-azatricyclo[4.3.1.13,8 ]undecane compounds |
| RU2162469C2 (ru) * | 1995-11-02 | 2001-01-27 | Ньюросерч А/С | Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов |
| EE200100096A (et) * | 1998-08-18 | 2002-06-17 | Ucb, S.A. | Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina |
| CA2348879A1 (en) * | 1998-11-02 | 2000-05-11 | Welfide Corporation | Pyrrolidine compound and pharmaceutical use thereof |
| CA2450167A1 (en) * | 2001-06-12 | 2002-12-19 | Elan Pharmaceuticals, Inc. | Macrocycles useful in the treatment of alzheimer's disease |
| US20050065178A1 (en) * | 2003-09-19 | 2005-03-24 | Anwer Basha | Substituted diazabicycloakane derivatives |
| US7482338B2 (en) * | 2003-09-26 | 2009-01-27 | Astrazeneca Ab | Non-amide nonanes |
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| TW200840569A (en) * | 2007-03-13 | 2008-10-16 | Targacept Inc | Sub-type selective amides of diazabicycloalkanes |
| US8168791B2 (en) * | 2007-03-23 | 2012-05-01 | Abbott Laboratories | Aminomethyl azaadamantane derivatives and methods of use thereof |
| MX2009010174A (es) * | 2007-03-23 | 2009-10-12 | Abbott Lab | Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos. |
| EP2069346B1 (en) * | 2007-03-23 | 2011-12-21 | Abbott Laboratories | Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
| CA2771885C (en) | 2009-09-14 | 2014-04-08 | Suven Life Sciences Limited | 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands |
-
2010
- 2010-06-18 US US12/818,764 patent/US8846661B2/en not_active Expired - Fee Related
- 2010-06-18 RU RU2012101784/04A patent/RU2549551C2/ru not_active IP Right Cessation
- 2010-06-18 RU RU2015110025/04A patent/RU2015110025A/ru not_active Application Discontinuation
- 2010-06-18 JP JP2012515322A patent/JP2012530084A/ja not_active Ceased
- 2010-06-18 WO PCT/CN2010/000889 patent/WO2010145208A1/en not_active Ceased
- 2010-06-18 NZ NZ597511A patent/NZ597511A/en not_active IP Right Cessation
- 2010-06-18 MX MX2011014019A patent/MX2011014019A/es active IP Right Grant
- 2010-06-18 AU AU2010262643A patent/AU2010262643B2/en not_active Ceased
- 2010-06-18 KR KR1020127001339A patent/KR20120044978A/ko not_active Withdrawn
- 2010-06-18 CA CA2765466A patent/CA2765466A1/en not_active Abandoned
- 2010-06-18 PE PE2011002111A patent/PE20121066A1/es not_active Application Discontinuation
- 2010-06-18 BR BRPI1015043A patent/BRPI1015043A2/pt not_active IP Right Cessation
- 2010-06-18 EP EP10788604.6A patent/EP2443122B1/en not_active Not-in-force
- 2010-06-18 SG SG2011094141A patent/SG176921A1/en unknown
- 2010-06-18 CN CN2010800368013A patent/CN102459268A/zh active Pending
-
2011
- 2011-12-08 IL IL216883A patent/IL216883A/en not_active IP Right Cessation
-
2015
- 2015-01-21 IL IL236830A patent/IL236830A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012530084A5 (enExample) | ||
| RU2015110025A (ru) | Производные диазагомоадамантана и способы их применения | |
| RU2386620C2 (ru) | Производные пиридазин-3(2н)-она и их применение в качестве ингибиторов фдэ4 | |
| US6048880A (en) | Pyridylfuran and pyridylthiophene compounds | |
| JP5865397B2 (ja) | α７ｎＡＣｈＲのモジュレータとして使用されるピロール誘導体 | |
| AU2012221800B2 (en) | Heteroaryl derivatives as alpha7 nAChR modulators | |
| RU2205827C2 (ru) | Производное ацилпиперазинилпиримидина, способы его получения, фармацевтическая композиция | |
| RU2010138640A (ru) | Производные 2-аза-бицикло [2.2.1] гептана | |
| JP2006507241A5 (enExample) | ||
| RU2006117789A (ru) | Производные дигидробензофуранилалканамина в качестве агонистов 5нт2с | |
| JP2008539195A (ja) | 新規のオキサジアゾール誘導体及びそれらの医学的使用 | |
| JP2005514398A5 (enExample) | ||
| RU2010125121A (ru) | Биарилзамещенные производные азабициклических алканов | |
| JP2008540637A5 (enExample) | ||
| JP2005539030A5 (enExample) | ||
| JP2009513700A5 (enExample) | ||
| RU2010129078A (ru) | Производные циклопропиламина | |
| JP2006527776A5 (enExample) | ||
| JP2003507366A5 (enExample) | ||
| RU2012134306A (ru) | Азотосодержащие производные гетероарилов | |
| CA2702482A1 (en) | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof | |
| RU2006143153A (ru) | 1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения | |
| JP2008525400A5 (enExample) | ||
| JP2009514801A5 (enExample) | ||
| JP2007515479A5 (enExample) |